Guidelines to the Abstract
International Congress of NanoBiotechnology & Nanomedicine 2009
June 22-24, 2009
San Francisco Airport Crowne Plaza
The International Association of
Nanotechnology is now accepting abstracts for the upcoming
3rd International Congress of Nanobiotechnology & Nanomedicine
2009, which will be held on June 22- 24, 2009 at the San
Francisco Airport Crowne Plaza, in San Francisco,
California, the USA.
Nano scale characterization
Nanoscale medical imaging
Heath Safety Implications
Venture capital investment
and other related topics
Intellectual Property and Technology Transfer
Education & Workforce Training
Societal & Environmental Impacts
Capital Funding and Grants for Start-up Ventures
How to submit an
speaking opportunity at the NanoBio 2009, please complete and
submit your abstract using the online form located at
If an official invitation is
necessary for you to obtain a visa to attend the meeting, please
complete the request for a formal invitation letter from the
For more information , please contact Program Coordinator at
should not exceed 500 words.
follow the format as outlined in the following
email your abstract in MS Word file (.doc file) and in Adobe
Acrobat format (.pdf) to
and submit the online form:
Guidelines for submitting a Research Summary
to the NanoiBio 2009
- An abstract
of up to 2 pages of scientific summary should be submitted by
April 1, 2009 by uploading your MS Word document onto the web site:
or sent via email to
Illustrations can be in black on white or in color.
Organization of a scientific abstract or a Research
The Research Summary is normally
arranged in the following order:
Author(s), and complete name(s) of institution(s).
City, state (province) and country. No telephone or
fax number should be included.
Email address of the principal author may be
Presents the purpose of the studies reported.
Executive Summary of Experimental Methods and Results:
A reader should gain a clear picture of the work with
sufficient subheadings to make clear how the work was
organized and what the key questions being addressed.
Concise and focused on the interpretation of the
Several key references in the text may be included with
citation as follows: two authors, Smith and Jones, 1996;
three or more authors, Smith et al., 1996. References to
papers by the same author(s) in the same year should be
distinguished in the text and the reference list by the
letters a, b, etc. (e.g. 1996a or 1996a, b). References
for journals and books should be in the following
MacDonald, G. M., Steenhuis, J. J., and Barry, B. A. (1995) J.
Biol. Chem. 270, 8420-8428.
Sambrook, J., Fritsch, E. F., and Maniatis,
T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold
Spring Harbor Laboratory, Cold Spring Harbor, NY.
Lay out of the Summary:
single spacing throughout, one-inch for all margins. The
title of the abstract should be in the text font Times
New Roman, size 14 and the main text is in text font
Times New Roman, size 12. The header should be blank,
but the footer should include the name of the conference
International Congress of Nanotechnology” and a main
topic of your research area i.e. “Nanomaterials”
in the text font Times Roman size 10.
A sample of an
abstract is shown here.
manuscripts to the NanoBio 2009 Proceedings
You are invited to submit your
manuscript to the Proceeding to the International Congress of
Nano Bio 2009
The Manuscript deadline is
June 6, 2009
here to view the
Guidelines for manuscript submission to the ICNCB
Official Invitation Letter
To request an official invitation letter for your Visa
application purpose, please complete the online form:
Frequently Asked Questions
Can I submit my
YES! It is highly recommended
submit your abstract online
via the Internet. To ensure the accuracy of the scientific
symbols used in the abstract and to assist the publisher in
printing your abstract in the Program Book, please send a copy of your abstract in both MS Word
and PDF file via email to
Can I submit my abstract on paper?
No, we no longer accept paper
abstracts by mail. Please send your abstract via the email
Do I have to be a member
of IANT to submit?
No. While you are
invited to become a member so as to receive membership
benefits such as substantial registration discount to
participate in the ICNT, membership of the Association is
not required when you submit your abstract.
May I submit more than one abstract as the presenter?
You can submit multiple abstracts
for poster presentations at the ICNT. However,
only one paper will be allowed for oral presentation.
Your name can be listed as a co-author on more than one abstract.
May I use tables, columns, or charts in my abstract?
Yes, but photos are not
recommended to be included in the abstract. Information included in the tables, columns, and charts must be the same font size as the text.
|How will I know if my abstract was accepted?
Notice of Acceptance will normally be announced within 1 - 2
weeks after the receipt of your abstract. You will receive your acceptance
letter via e-mail. Therefore, it is vital that you use a valid, permanent e-mail address.
If you have not heard from us about the status of your
abstract after 4 weeks from the date of your submission,
please feel free to send your enquiry to
|Do presenters have to pre-register for the meeting?
speakers and poster presenters must confirm their
participation by completing the registration by the
pre-registration date in order to have the special discount.
May I submit my paper to the
conference proceeding ?
Once your abstract is accepted, you are invited to submit your manuscript to the
conference proceeding. Please see the deadline of manuscript
Submission Terms and Conditions
Persons submitting an abstract to
the IANANO conferences are doing so with the understanding that they abide by the conditions, deadline policies, and the decisions of the
All presentations offered at the meeting shall be made with the understanding that there shall be a complete explanation of material presented in the abstract submitted. Submission of an abstract carries with it the obligation of the author to present the paper in person. Presenters are expected to respond to audience inquiries regarding items under presentation. Both oral and poster discussion sessions will be interactive, with a moderator. The official language of the meeting and all communications will be English.
All presenters must pre-register for the meeting and pay the appropriate registration fee
after the abstract being accepted to be eligible for special speaker registration rate.
As a non-profit and
non-government organization, the International Association of
Nanotechnology is financially independent from any governments,
corporations or any entities, which enables us to be serve as an
independent think tank in various controversial issues facing
the emerging technology. Your contribution in the form of
registration would help to defray the high cost of organizing an
Abstract Preparation Instructions:
Authors are invited to submit abstracts, up to two pages in
length, including text and figures for consideration.
be placed on the first page, figures occupying the
second page. The abstract must explicitly highlight the
new aspects of the work and conclusions that can be
drawn; main results must be clearly indicated. The
abstract shall be no more than 500 words in length,
using no smaller than 12-point type (Times New Roman).
The abstract should include the paper title, author's
name, affiliation, address, fax and telephone numbers
and e-mail. Underline the presenting author and at the
bottom of your abstract, indicate the topic area of your
An individual may submit more
than one abstract and may present only one paper at the meeting, but may appear as a co-author on other abstracts.
The primary author must have the consent of all co-authors listed on the abstract prior to submission.
Presenters must not split one study into several papers. Each abstract must stand independently on its own merit. Multiple titles (series titles or numeric titles) will be rejected.
The research project being reported in the abstract must
be able to demonstrate some elements of originality or carry
with it new insights and refreshing ideas for the advancement of
knowledge. Abstracts will not be accepted if the same work have been previously published or presented at another meeting,
unless additional work or new results or new insight can be
presented at the conference.
The Group Program Chairs selected for each Review Group and the Annual Session Committee reserve the right to reclassify submitted abstracts into the most appropriate area of review.
Mode of Presentations:
The conference will include presentations in the following modes:
Oral Presentation: Presenters with an accepted abstract will be sent more detailed instructions as the meeting approaches.
The time allotment for an each oral presentation is normally
25 minutes, followed by five minutes of discussion.
Poster Presentation: Poster session is an important session at the International
Congress. It is a great opportunity for
authors to present papers at the ICNT while meeting with
interested attendees for in-depth technical discussions.
All authors are invited submit
the full paper to the conference proceedings.
Please view the Guidelines for
Poster Preparation and Presentation
The author must indicate, during the online abstracts submission process, if he/she prefers to present his/her report in the oral, or poster discussion mode.
If no preference is not given, the Group Program Chairs will determine the final mode of presentation. Efforts will be made to comply with author preference; however, the submitter is obligated to present in the mode assigned unless he/she indicates that the abstract will be withdrawn. After the abstracts are accepted and
included in the program, no changes can be made in the mode of presentation.
All submitted abstracts will go through a peer
review process and it may take 2 to 4 weeks to have a
final feedback and decision. Final oral, poster and approval decisions
are based upon these reviews.
Presentations will be selected for the program on the basis of the scientific quality of the work as judged from the abstract. An impartial panel of reviewers (three persons per Group) will evaluate the content of each abstract. Selection of the abstracts will be made by these reviewers and by the Session Committee, whose decision is final.
Abstracts will be reviewed and selected according to how
well they address the following questions:
What is the new accomplishment in relation to
|b. What is the
significance of the new results to the field of
Nanotechnology, Nanobiotechnology and Nanomedicine
The following are the evaluation criteria used in the review of abstracts. This is provided to call your attention to points that will be considered. In the final analysis, it will be the reviewers' judgment of the value of any abstract that will determine whether the abstract should appear on the program.
Since the abstracts are published and become part of the world's scientific literature, it is important that the content be scientifically sound and grammatically correct. Each abstract is reviewed so that high standards can be ensured.
Reasons for Rejection are:
l. Abstract poorly organized and/or not complete.
2. Required information not given in abstract:
- results — data and statistical analysis, or
3. Nature of problem not explicit from either title or abstract.
4. Material too closely related to another submitted abstract by same co-authors; should have been combined into a single paper.
5. Abstract is not original research.
6. Abstract has been presented at other
meetings or previously published.
7. Problem fairly well-defined, but its importance doubtful.
8. No well-defined criteria given for evaluation of variables.
9. Choice of controls questionable.
10. No control groups reported.
11. Methods of obtaining data not appropriate with respect to the stated problem for the following reasons:
a. Methods not sufficiently precise to permit the measurements to be accurate, i.e., variations are within the error limits for the method.
b. Sampling method contains inherent discriminatory factors not recognized.
c. Size of sample insufficient to show significant conformity or differences.
- Confusion between the initial premises (assumptions) and measurements (factors data) leads to faulty reasoning.
- Conclusions not clear.
13. Conclusions do not necessarily follow as a consequence of the method of analysis applied to the data.
14. Conclusions not adequately qualified, i.e., conclusions have greater limitations than implied by the author.
15. Correlations suggested may be fortuitous insofar as no plausible cause-and-effect relation has been suggested, and none is obvious.
16. Abstract is not in English.
If you have any special requests—i.e., religious, academic, or personal conflicts—or if you wish to request that abstracts be scheduled in a specific order, please
contact the Program Coordinator:
Withdrawal of Papers:
Requests to withdraw papers must be made in writing by the presenter (requests from anyone other than the presenter will not be honored) and submitted to the Central Office
2 weeks prior to the meeting. Please send withdrawal requests to Program Manager, at firstname.lastname@example.org you must give the reason for withdrawing the abstract. Lack of travel funds is not an acceptable reason to withdraw an abstract or delegate a substitute presenter. Authors who are dependent on Government or institutional funding for travel should ensure that such funds will be available
contingent upon the acceptance of the abstract, or be prepared to participate in the meeting at their own expense. Failure to follow the above procedure may result in the presenter being charged the full registration fee and/or not being allowed to present at a future meeting.
If the presenter is unable to attend the meeting, he/she may name a substitute. The substitute must be a co-author and should not be presenting another abstract at the meeting. Requests for presenter changes should be made in writing via e-mail to Program
Coordinator at email@example.com. Requests should contain the reason for the changes and both the original and new presenters' names. All requests
for changes must be submitted
30 days prior to the conference.
Should you have any questions,
please contact the Program Coordinator at 408-280-6222 or email
or the Program Director at